# Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope

Study · id `cardio:ct-nct05987670` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05987670](<https://clinicaltrials.gov/study/NCT05987670>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05987670

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 200 participants.

## Technical summary

Registry record NCT05987670. Randomized; no masking; primary purpose diagnostic. Start 2023-10-25 (actual); primary completion 2028-06-23 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT05987670, source copy `cardio:ctgov-nct05987670-2026-11-10`, retrieved 2026-11-18)
- Started: 2023-10-25 (actual) (ClinicalTrials.gov record NCT05987670, source copy `cardio:ctgov-nct05987670-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2028-06-23 (anticipated) (ClinicalTrials.gov record NCT05987670, source copy `cardio:ctgov-nct05987670-2026-11-10`, retrieved 2026-11-18)
- Completion: 2028-06-23 (anticipated) (ClinicalTrials.gov record NCT05987670, source copy `cardio:ctgov-nct05987670-2026-11-10`, retrieved 2026-11-18)
- Countries: United Kingdom (ClinicalTrials.gov record NCT05987670, source copy `cardio:ctgov-nct05987670-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05987670-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope
- Acronym: TRICORDER
- Condition: Heart Failure
- Condition: Heart Valve Diseases
- Condition: Atrial Fibrillation
- Condition: Heart Murmurs
- Condition: Congestive Heart Failure
- Condition: Heart Failure With Reduced Ejection Fraction
- Intervention (Device): AI-stethoscope
- Lead sponsor: Imperial College London
- Lead sponsor class: OTHER
- Collaborator: Imperial College Health Partners (ICHP)
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Imperial College London (`cardio:org-imperial-college-london`)

## Provenance

Content hash: 4c301545cd55bd1a2e0e42e67b92c81c10a248adb2d2b2fb269374c02e69a99d
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
